{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:31:41Z","timestamp":1774045901207,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,1,19]],"date-time":"2004-01-19T00:00:00Z","timestamp":1074470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1038\/sj.npp.1300415","type":"journal-article","created":{"date-parts":[[2004,3,10]],"date-time":"2004-03-10T11:15:59Z","timestamp":1078917359000},"page":"991-1003","source":"Crossref","is-referenced-by-count":26,"title":["Transdermal Nicotine Maintenance Attenuates the Subjective and Reinforcing Effects of Intravenous Nicotine, but not Cocaine or Caffeine, in Cigarette-Smoking Stimulant Abusers"],"prefix":"10.1038","volume":"29","author":[{"given":"Bai-Fang X","family":"Sobel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey C","family":"Sigmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland R","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,1,19]]},"reference":[{"key":"BF1300415_CR1","unstructured":"American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC."},{"key":"BF1300415_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0899-3289(93)90056-H","volume":"5","author":"AJ Budney","year":"1993","unstructured":"Budney AJ, Higgins ST, Highes JR, Bickel WK (1993). Nicotine and caffeine use in cocaine-dependent individuals. J Subst Ab 5: 117\u2013130.","journal-title":"J Subst Ab"},{"key":"BF1300415_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-012347360-8\/50004-5","volume-title":"Cocaine Abuse: Behavior, Pharmacology, and Clinical Applications","author":"SB Caine","year":"1998","unstructured":"Caine SB (1998). Neuroanatomical bases of the reinforcing stimulus effects of cocaine. In: Higgins ST, Katz JL (eds). Cocaine Abuse: Behavior, Pharmacology, and Clinical Applications. Academic Press: San Diego. pp 21\u201349."},{"key":"BF1300415_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0014-2999(00)00122-9","volume":"393","author":"G Di Chiara","year":"2000","unstructured":"Di Chiara G (2000). Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393: 295\u2013314.","journal-title":"Eur J Pharmacol"},{"key":"BF1300415_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0376-8716(02)00327-7","volume":"69","author":"EC Donny","year":"2003","unstructured":"Donny EC, Bigelow GE, Walsh SL (2003). Choosing to take cocaine in the human laboratory: effects of cocaine dose, inter-choice interval, and magnitude of alternative reinforcement. Drug Alcohol Depend 69: 289\u2013301.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300415_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF02245285","volume":"108","author":"S Evans","year":"1992","unstructured":"Evans S, Griffiths RR (1992). Caffeine tolerance and choice in humans. Psychopharmacology 108: 51\u201359.","journal-title":"Psychopharmacology"},{"key":"BF1300415_CR7","first-page":"247","volume":"257","author":"RW Foltin","year":"1991","unstructured":"Foltin RW, Fischman MW (1991a). Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257: 247\u2013261.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300415_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0376-8716(91)90052-Z","volume":"28","author":"RW Foltin","year":"1991","unstructured":"Foltin RW, Fischman MW (1991b). Assessment of abuse liability of stimulant drugs in humans: a methodological survey. Drug Alcohol Depend 28: 3\u201348.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300415_CR9","first-page":"841","volume":"261","author":"RW Foltin","year":"1992","unstructured":"Foltin RW, Fischman MW (1992). Self-administration of cocaine by humans: choice between smoked and intravenous cocaine. J Pharmacol Exp Ther 261: 841\u2013849.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300415_CR10","first-page":"83","volume":"51","author":"BB Fredholm","year":"1999","unstructured":"Fredholm BB, B\u00e4ttig K, Holm\u00e9n J, Nehlig A, Zvartau EE (1999). Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51: 83\u2013133.","journal-title":"Pharmacol Rev"},{"key":"BF1300415_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0091-3057(96)00435-2","volume":"57","author":"BE Garrett","year":"1997","unstructured":"Garrett BE, Griffiths RR (1997). The Role of dopamine in the behavioral effects of caffeine in animals and humans. Pharmacol Biochem Behav 57: 533\u2013541.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300415_CR12","first-page":"486","volume":"296","author":"BE Garrett","year":"2001","unstructured":"Garrett BE, Griffiths RR (2001). Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers. J Pharmacol Exp Ther 296: 486\u2013494.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300415_CR13","first-page":"1699","volume-title":"Psychopharmacology: The Fourth Generation on Progress","author":"RR Griffiths","year":"1995","unstructured":"Griffiths RR, Mumford GK (1995). Caffeine \u2014 a drug of abuse?. In: Bloom FE, Kupfer DJ (eds). Psychopharmacology: The Fourth Generation on Progress. Raven Press: New York. pp 1699\u20131713."},{"key":"BF1300415_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00008877-199302000-00001","volume":"4","author":"RR Griffiths","year":"1993","unstructured":"Griffiths RR, Troisi JR, Silverman K, Mumford GK (1993). Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav Pharmacol 4: 3\u201313.","journal-title":"Behav Pharmacol"},{"key":"BF1300415_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1037\/1064-1297.4.1.97","volume":"4","author":"RR Griffiths","year":"1996","unstructured":"Griffiths RR, Rush CR, Puhala KA (1996). Validation of the multiple-choice procedure for investigating drug reinforcement in humans. Exp Clin Psychopharmacol 4: 97\u2013106.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BF1300415_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1037\/1064-1297.2.2.115","volume":"2","author":"DK Hatsukami","year":"1994","unstructured":"Hatsukami DK, Thompson TN, Pentel PR, Flygare BK, Carroll ME (1994). Self-administration of smoked cocaine. Exp Clin Psychopharmacol 2: 115\u2013126.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BF1300415_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s002130000541","volume":"152","author":"SJ Heishman","year":"2000","unstructured":"Heishman SJ, Henningfield JE (2000). Tolerance to repeated nicotine administration on performance, subjective, and physiological responses in nonsmokers. Psychopharmacology 152: 321\u2013333.","journal-title":"Psychopharmacology"},{"key":"BF1300415_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0024-3205(94)00878-7","volume":"55","author":"ST Higgins","year":"1994","unstructured":"Higgins ST, Bickel WK, Hughes JR (1994a). Influence of an alternative reinforcer on human cocaine self-administration. Life Sci 55: 179\u2013187.","journal-title":"Life Sci"},{"key":"BF1300415_CR19","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1001\/jama.1994.03520220018016","volume":"272","author":"ST Higgins","year":"1994","unstructured":"Higgins ST, Budney AJ, Hughes JR, Bickel WK, Lynn M, Mortensen A (1994b). Influence of cocaine use on cigarette smoking. J Am Med Assoc 272: 1724.","journal-title":"J Am Med Assoc"},{"key":"BF1300415_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/14622200050147529","volume":"2","author":"JR Hughes","year":"2000","unstructured":"Hughes JR, Rose GL, Callas PW (2000). Do former smokers respond to nicotine differently from never smoker? A pilot study. Nic Tob Res 2: 255\u2013262.","journal-title":"Nic Tob Res"},{"key":"BF1300415_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1037\/0033-2909.95.2.301","volume":"95","author":"J Istvan","year":"1984","unstructured":"Istvan J, Matarazzo JD (1984). Tobacco, alcohol, and caffeine use: a review of their interrelationships. Psychol Bull 95: 301\u2013326.","journal-title":"Psychol Bull"},{"key":"BF1300415_CR22","first-page":"188","volume":"288","author":"HE Jones","year":"1999","unstructured":"Jones HE, Garrett BE, Grifffiths RR (1999). Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers. J Pharmacol Exp Ther 288: 188\u2013197.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300415_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00213-002-1262-4","volume":"165","author":"HE Jones","year":"2003","unstructured":"Jones HE, Griffiths RR (2003). Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers. Psychopharmacology 165: 280\u2013290.","journal-title":"Psychopharmacology"},{"key":"BF1300415_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1176\/jnp.9.3.482","volume":"9","author":"GF Koob","year":"1997","unstructured":"Koob GF, Nestler EJ (1997). The neurobiology of drug addiction. J Neuropsych Clin Neurosci 9: 482\u2013497.","journal-title":"J Neuropsych Clin Neurosci"},{"key":"BF1300415_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0091-3057(01)00529-9","volume":"69","author":"EM Kouri","year":"2001","unstructured":"Kouri EM, Stull M, Lukas SE (2001). Nicotine alters some of cocaine's subjective effects in the absence of physiological or pharmacokinetic changes. Pharmacol Biochem Behav 69: 209\u2013217.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300415_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","volume":"14","author":"MJ Kuhar","year":"1991","unstructured":"Kuhar MJ, Ritz MC, Boja JW (1991). The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14: 299\u2013302.","journal-title":"Trends Neurosci"},{"key":"BF1300415_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00004714-199402000-00006","volume":"14","author":"ED Levin","year":"1994","unstructured":"Levin ED, Westman EC, Stein RM, Carnahan E, Sanchez M, Herman S et al. (1994). Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. J Clin Psychopharmacol 14: 41\u201349.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1300415_CR28","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/clpt.1982.91","volume":"31","author":"DC May","year":"1982","unstructured":"May DC, Jarboe CH, VanBakel AB, Williams WM (1982). Effects of cimetidine on caffeine disposition in smokers and nonsmokers. Clin Pharmacol Ther 31: 656\u2013661.","journal-title":"Clin Pharmacol Ther"},{"key":"BF1300415_CR29","first-page":"570","volume":"272","author":"GK Mumford","year":"1995","unstructured":"Mumford GK, Rush CR, Griffths RR (1995). Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 272: 570\u2013580.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300415_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0091-3057(86)90156-5","volume":"25","author":"R Nemeth-Coslett","year":"1986","unstructured":"Nemeth-Coslett R, Henningfield JE, Katz J, Goldberg S (1986). Effect of cocaine on rate of cigarette smoking. Pharmacol Biochem Behav 25: 303.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300415_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/cpt197824140","volume":"24","author":"WD Parsons","year":"1978","unstructured":"Parsons WD, Neims AH (1978). Effect of smoking on caffeine clearance. Clin Pharmacol Ther 24: 40\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"BF1300415_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/1462220021000018425","volume":"4","author":"KA Perkins","year":"2002","unstructured":"Perkins KA (2002). Chronic tolerance to nicotine in humans and its relationship to tobacco dependence. Nic Tob Res 4: 405\u2013422.","journal-title":"Nic Tob Res"},{"key":"BF1300415_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1037\/1064-1297.9.3.243","volume":"3","author":"KA Perkins","year":"2001","unstructured":"Perkins KA, Gerlach D, Broge M, Fonte C, Wilson A (2001). Reinforcing effects of nicotine as a function of smoking status. Exp Clin Psychopharmacol 3: 243\u2013250.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BF1300415_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0091-3057(93)90254-Q","volume":"45","author":"KA Perkins","year":"1993","unstructured":"Perkins KA, Grobe JE, Epstein LH, Caggiula A, Stiller RL, Jacob RG (1993). Chronic and acute tolerance to subjective effects of nicotine. Pharmacol Biochem Behav 45: 375\u2013381.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300415_CR35","first-page":"628","volume":"270","author":"KA Perkins","year":"1994","unstructured":"Perkins KA, Grobe JE, Fonte C, Goettler J, Caggiula AR, Reynolds WA et al. (1994). Chronic and acute tolerance to subjective, behavioral, and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther 270: 628\u2013638.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300415_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0165-6147(03)00230-X","volume":"24","author":"MR Picciotto","year":"2003","unstructured":"Picciotto MR (2003). Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci 24: 493\u2013499.","journal-title":"Trends Pharmacol Sci"},{"key":"BF1300415_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF02244745","volume":"115","author":"WB Pickworth","year":"1994","unstructured":"Pickworth WB, Bunker EB, Henningfield JE (1994). Transdermal nicotine: reduction of smoking with minimal abuse liability. Psychopharmacology 115: 9\u201314.","journal-title":"Psychopharmacology"},{"key":"BF1300415_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0376-8716(97)00144-0","volume":"49","author":"MS Reid","year":"1998","unstructured":"Reid MS, Mickalian JD, Delucchi KL, Hall SM, Berger SP (1998). An acute dose of nicotine enhances cue-induced cocaine craving. Drug Alcohol Depend 49: 95\u2013104.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300415_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0376-8716(96)01219-7","volume":"40","author":"JM Roll","year":"1996","unstructured":"Roll JM, Higgins ST, Budney AJ, Bickel WK, Badger GJ (1996). A comparison of cocaine-dependent cigarette smokers on demographics, drug use and other characteristics. Drug Alcohol Depend 40: 195\u2013201.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300415_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1037\/1064-1297.5.3.263","volume":"5","author":"JM Roll","year":"1997","unstructured":"Roll JM, Higgins ST, Tidey JW (1997). Cocaine use can increase cigarette smoking: evidence from laboratory and naturalistic settings. Exp Clin Psychopharmacol 5: 263\u2013268.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BF1300415_CR41","first-page":"351","volume":"273","author":"CR Rush","year":"1995","unstructured":"Rush CR, Sullivan JT, Griffiths RR (1995). Intravenous caffeine in stimulant drug abusers: subjective reports and physiological effects. J Pharmacol Exp Ther 273: 351\u2013358.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300415_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s002130050246","volume":"130","author":"KJ Schuh","year":"1997","unstructured":"Schuh KJ, Griffiths RR (1997). Caffeine reinforcement: the role of withdrawal. Psychopharmacology 130: 320\u2013326.","journal-title":"Psychopharmacology"},{"key":"BF1300415_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s002130050896","volume":"142","author":"M Shoaib","year":"1999","unstructured":"Shoaib M, Swanner LS, Yasar S, Goldberg SR (1999). Chronic caffeine exposure potentiates nicotine self-administration in rats. Psychopharmacology 142: 327\u2013333.","journal-title":"Psychopharmacology"},{"key":"BF1300415_CR44","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s002130100740","volume":"156","author":"BJ Smith","year":"2001","unstructured":"Smith BJ, Jones HE, Griffiths RR (2001). Physiological, subjective and reinforcing effects of oral and intravenous cocaine in humans. Psychopharmacology 156: 435\u2013444.","journal-title":"Psychopharmacology"},{"key":"BF1300415_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s002130050129","volume":"128","author":"R Soria","year":"1996","unstructured":"Soria R, Stapleton JM, Gilson SF, Sampson-Cone A, Henningfield JE, London ED (1996). Subjective and cardiovascular effects of intravenous nicotine in smokers and nonsmokers. Psychopharmacology 128: 221\u2013226.","journal-title":"Psychopharmacology"},{"key":"BF1300415_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0306-4603(94)90027-2","volume":"19","author":"JA Swanson","year":"1994","unstructured":"Swanson JA, Lee JW, Hopp JW (1994). Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal. Addict Behav 19: 229\u2013256.","journal-title":"Addict Behav"},{"key":"BF1300415_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0091-3057(00)00234-3","volume":"66","author":"G Tanda","year":"2000","unstructured":"Tanda G, Goldberg SR (2000). Alteration of the behavioral effects of nicotine by chronic caffeine exposure. Pharmacol Biochem Behav 66: 47\u201364.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300415_CR48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s002130000439","volume":"150","author":"SL Walsh","year":"2000","unstructured":"Walsh SL, Haberny KA, Bigelow GE (2000). Modulation of intravenous cocaine effects by chronic oral cocaine in humans. Psychopharmacology 150: 361\u2013373.","journal-title":"Psychopharmacology"},{"key":"BF1300415_CR49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/BF00215491","volume":"92","author":"RJ West","year":"1987","unstructured":"West RJ, Russell MAH (1987). Cardiovascular and subjective effects of smoking before and after 24 h of abstinence from cigarettes. Psychopharmacology 92: 118\u2013121.","journal-title":"Psychopharmacology"},{"key":"BF1300415_CR50","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3109\/00952999609001682","volume":"22","author":"EJ Wiseman","year":"1996","unstructured":"Wiseman EJ, McMillan DE (1996). Combined use of cocaine with alcohol or cigarettes. Am J Drug Alcohol Abuse 22: 577\u2013587.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BF1300415_CR51","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0893-133X(00)00224-4","volume":"24","author":"V Zachariou","year":"2001","unstructured":"Zachariou V, Caldarone BJ, Weathers-Lowin A, George TP, Elsworth JD, Roth RH et al (2001). Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacol 24: 576\u2013589.","journal-title":"Neuropsychopharmacol"},{"key":"BF1300415_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(97)01184-9","volume":"337","author":"G Zernig","year":"1997","unstructured":"Zernig G, O'Laughlin IA, Fibiger HC (1997). Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens. Eur J Pharmacol 337: 1\u201310.","journal-title":"Eur J Pharmacol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300415","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:46:02Z","timestamp":1684219562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,19]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["BF1300415"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300415","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,19]]}}}